CDC25C and breast carcinoma: Indeed, RPPA data revealed an enrichment of cell cycle‐related genes including CDC25C and PLK1 in proteins downregulated by metformin, echoing a previous report showing selective translational inhibition of cell cycle regulators such as cyclin E2 and ODC1 by metformin in breast cancer cells (Larsson et al., 2012).